Advertisement

Haloperidol Decanoate Injection

[06 November 2016]

Products Affected - Description

Haloperidol Decanoate injection, Fresenius Kabi
50 mg/mL, 1 mL vial, 1 count (NDC 63323-0469-01)
 
Haloperidol decanoate injection, Teva
50 mg/mL, 1 mL vial, 10 count  (NDC 00703-7011-03)
50 mg/mL, 5 mL vial, 1 count  (NDC 00703-7013-01)
100 mg/mL, 1 mL vial, 10 count  (NDC 00703-7021-03)
100 mg/mL, 5 mL vial, 1 count  (NDC 00703-7023-01)

Reason for the Shortage

  • Teva products are on shortage due to manufacturing delays.
  • West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired haloperidol decanoate injection from Bedford in July 2014. West-Ward is not actively marketing haloperidol decanoate injection at this time. .
  • Fresenius Kabi has haloperidol decanoate on shortage due to short-term manufacturing delays.

Available Products

Haldol decanoate injection, Janssen-Ortho-McNeil
50 mg/mL, 1 mL ampule, 3 count (NDC 50458-0253-03)
100 mg/mL, 1 mL ampule, 3 count (NDC 50458-0254-14)
 
Haloperidol decanoate injection, Fresenius Kabi
50 mg/mL, 5 mL vial, 1 count  (NDC 63323-0469-05)
100 mg/mL, 1 mL vial, 1 count (NDC 63323-0471-01)
100 mg/mL, 5 mL vial, 1 count  (NDC 63323-0471-05)
 
Haloperidol Decanoate injection, Mylan Institutional
50 mg/mL, 1 mL vial, 10 count (NDC 67457-0410-13)
50 mg/mL, 5 mL vial, 5 count (NDC 67457-0382-58)
100 mg/mL, 1 mL vial, 5 count (NDC 67457-0409-13)
100 mg/mL, 5 mL vial, 5 count (NDC 67457-0381-58)
 
Haloperidol decanoate injection, Patriot Pharmaceuticals
50 mg/mL, 1 mL ampule, 3 count  (NDC 10147-0921-03)
100 mg/mL, 1 mL ampule, 3 count  (NDC 10147-0922-05)

Estimated Resupply Dates

  • Fresenius Kabi has haloperidol decanoate 50 mg/mL 1 mL vials on back order and the company estimates a release date of 1st quarter 2017.
  • Teva has all haloperidol decanoate presentations on long-term back order and the company estimates a release date in 1st quarter 2017.

Related Shortages

Updated

November 6, August 10 and 1, June 21, May 4, March 10 and 9, January 6, 2016; November 11, September 16, August 6 and 4, June 2, May 11, April 29, March 23 and 13, February 23 and 13, January 14, 2015; December 18, November 24 and 11, October 23 and 13, September 24 and 3, August 7, July 17 and 9, June 30 and 26, April 24, 2014; December 11, September 30, August 5, June 3, March 22, February 28, 2013; December 12, October 10, June 1, April 6, March 19 and 9, January 27, 2012; December 21 and 16, October 4, June 23, May 27, 11 and 4, April 13, March 22 and 9, February 28 and 2, January 25 and 6, 2011; December 15, October 14 and 1, August 30, July 20, 9 and 7, June 25 and 17, May 21, April 30, March 18, February 17, January 11, 2010; December 23 and 1, October 29 and 8, September 21, August 26 and 3, June 30, 16 and 1, May 12, April 1, 2009, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing